Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulation of Tumor-Associated Myeloid Cell Activity by CBP/EP300 Bromodomain Modulation of H3K27 Acetylation
Denise E. de Almeida Nagata, Eugene Y. Chiang, Suchit Jhunjhunwala, et al.
Cell Reports (2019) Vol. 27, Iss. 1, pp. 269-281.e4
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

MDSC: Markers, development, states, and unaddressed complexity
Samarth Hegde, Andrew M. Leader, Miriam Mérad
Immunity (2021) Vol. 54, Iss. 5, pp. 875-884
Open Access | Times Cited: 464
Targeting the epigenetic regulation of antitumour immunity
Simon J. Hogg, Paul A. Beavis, Mark A. Dawson, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 11, pp. 776-800
Closed Access | Times Cited: 454
Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps
Bob Chen, Cherie’ R. Scurrah, Eliot T. McKinley, et al.
Cell (2021) Vol. 184, Iss. 26, pp. 6262-6280.e26
Open Access | Times Cited: 203
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Enyong Dai, Zhi Zhu, Shudipto Wahed, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 187
Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents
Qingjuan Chen, Bin-Hui Yang, Xiaochen Liu, et al.
Theranostics (2022) Vol. 12, Iss. 11, pp. 4935-4948
Open Access | Times Cited: 112
Methylation across the central dogma in health and diseases: new therapeutic strategies
Ruochen Liu, Erhu Zhao, Huijuan Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 56
The Role of CREBBP/EP300 and Its Therapeutic Implications in Hematological Malignancies
Yu Zhu, Zi Wang, Yanan Li, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1219-1219
Open Access | Times Cited: 54
Circulating tumor cells: from new biological insights to clinical practice
Xuyu Gu, Shiyou Wei, Xin Lv
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 32
Epigenetic regulation in cancer
Minzhi Gu, Bo Ren, Yuan Fang, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 18
Protein lysine acetyltransferase CBP/p300: A promising target for small molecules in cancer treatment
Panhong Gou, Wenchao Zhang
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116130-116130
Open Access | Times Cited: 12
Programs, origins and immunomodulatory functions of myeloid cells in glioma
Tyler E. Miller, Chadi El Farran, Charles P. Couturier, et al.
Nature (2025)
Open Access | Times Cited: 1
The epigenetic hallmarks of immune cells in cancer
Ji Yu, Chu Xiao, Tao Fan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy
Francesco De Sanctis, Annalisa Adamo, Stefania Canè, et al.
Seminars in Immunopathology (2022) Vol. 45, Iss. 2, pp. 163-186
Open Access | Times Cited: 36
Epigenetic regulation and therapeutic targets in the tumor microenvironment
Zhuojun Xie, Zirui Zhou, Shuxian Yang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 21
The Killer’s Web: Interconnection between Inflammation, Epigenetics and Nutrition in Cancer
Marisabel Mecca, Simona Picerno, Salvatore Cortellino
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2750-2750
Open Access | Times Cited: 8
Epigenetic regulation of tumor immunity
Lizhi Pang, Fei Zhou, Yang Liu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 12
Open Access | Times Cited: 8
Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies
Lenka Trnkova, Verona Buociková, Michal Mego, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116559-116559
Open Access | Times Cited: 7
Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment
Xingyi Pan, Lei Zheng
Cellular and Molecular Immunology (2020) Vol. 17, Iss. 9, pp. 940-953
Open Access | Times Cited: 50
LINC00941 promotes oral squamous cell carcinoma progression via activating CAPRIN2 and canonical WNT/β‐catenin signaling pathway
Yilong Ai, Siyuan Wu, Chen Zou, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 18, pp. 10512-10524
Open Access | Times Cited: 40
STAT1 epigenetically regulates LCP2 and TNFAIP2 by recruiting EP300 to contribute to the pathogenesis of inflammatory bowel disease
Yali Yu, Meng Chen, Hua Zhu, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 35
Epigenetics of Dendritic Cells in Tumor Immunology
Gerard Godoy‐Tena, Esteban Ballestar
Cancers (2022) Vol. 14, Iss. 5, pp. 1179-1179
Open Access | Times Cited: 20
Tumor microenvironment, histone modifications, and myeloid-derived suppressor cells
Xinyu Tian, Ting Wang, Han Shen, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 74, pp. 108-121
Closed Access | Times Cited: 11
Epigenetic Regulation of Stromal and Immune Cells and Therapeutic Targets in the Tumor Microenvironment
Kang Liu, Yue Li, Minmin Shen, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 71-71
Open Access
Epigenetic Modification and Tumor Immunity: Unraveling the Interplay with the Tumor Microenvironment and its Therapeutic Vulnerability and Implications
Huaijin Zheng, Yuze Hua, Sen Yang, et al.
Cancer Letters (2025) Vol. 616, pp. 217587-217587
Closed Access
Histone acetylation modulators in breast cancer
Xueying Yuan, Jeffrey M. Rosen
Breast Cancer Research (2025) Vol. 27, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top